NYSE · Common Stock · Surgical & Medical Instruments & Apparatus
38 entities across 28 jurisdictions, 1 in offshore financial centres. Read directly from the company’s own 10-K EX-21 filed 2026-02-18 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Artivion Chile SpA | Chile | |
| Artivion Colombia SAS | Colombia | |
| Artivion Cyprus Limited | Cyprus | offshore centre |
| Artivion EMEA GmbH | Germany | |
| Artivion France S.A.S. | France | |
| Artivion Hellas Single Member Ltd. | Greece | |
| Artivion Hong Kong, Limited | Hong Kong | |
| Artivion India Private Limited | India | |
| Artivion Italy s.r.l. | Italy | |
| Artivion LATAM Holdings Spain, SLU | Spain | |
| Artivion Malaysia, Sdn. Bhd. | Malaysia | |
| Artivion México, S.A. de C.V. | Mexico | |
| Artivion New Zealand | New Zealand | |
| Artivion Polska Sp. z.o.o. | Poland | |
| Artivion Spain, s.r.l. | Spain | |
| Artivion Taiwan Co. Limited | Taiwan | |
| Artivion UK Ltd. | England and Wales | |
| Ascyrus Medical GmbH | Germany | |
| Ascyrus Medical LLC | Florida | |
| AuraZyme Pharmaceuticals, Inc. | Florida | |
| CryoLife Asia Pacific, PTE. Ltd | Singapore | |
| CryoLife Beijing Medical Device Ltd. | China | |
| CryoLife Canada, Inc. | Canada | |
| CryoLife Germany HoldCo GmbH | Germany | |
| CryoLife Germany TopCo GmbH | Germany | |
| CryoLife International, Inc. | Florida | |
| CryoLife Korea Co., Ltd. | Korea | |
| CryoLife Medical (Australia) Co. Pty, Ltd. | Australia | |
| CryoLife Medical (Thailand) Co., Ltd. | Thailand | |
| CryoLife Vietnam Co., Ltd. | Vietnam | |
| Jolly Buyer Acquisition GmbH | Switzerland | |
| JOTEC do Brasil Ltda. | Brazil | |
| JOTEC GmbH | Germany | |
| JOTEC Sales GmbH | Switzerland | |
| JOTEC UK Ltd. | England | |
| On-X Life Technologies Holdings, Inc. | Delaware | |
| On-X Life Technologies, Inc. | Delaware | |
| Valve Special Purpose Co., LLC | Delaware |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $253.2M | −$16.7M | $5.0M | 66.3% | 37,861,000 |
| FY2021 | $298.8M | −$14.8M | −$15.7M | 66.1% | 38,983,000 |
| FY2022 | $313.8M | −$19.2M | −$14.2M | 64.5% | 40,032,000 |
| FY2023 | $354.0M | −$30.7M | $11.4M | 64.7% | 40,743,000 |
| FY2024 | $388.5M | −$13.4M | $11.0M | 64.0% | 41,676,000 |
| FY2025 | $441.3M | $9.8M | $839,000 | 64.4% | 47,162,000 |
12 institutions tracked — 7 added, 4 reduced, 1 opened a new position.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | Hedge fund | 827,594 | +756,725 | $18.6M |
| FMR LLC | Active fund | 1,963,471 | −619,956 | $44.1M |
| MORGAN STANLEY | Active fund | 2,557,961 | +288,667 | $57.5M |
| BlackRock, Inc. | Index | 6,674,017 | +199,163 | $150.0M |
| STATE STREET CORP | Index | 1,858,051 | +175,778 | $41.8M |
| WELLINGTON MANAGEMENT GROUP LLP | Active fund | 1,260,279 | +103,592 | $28.3M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 71,564 | +19,221 | $1.6M |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 1,114,297 | −18,206 | $25.0M |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 14,383 | −3,913 | $323,186 |
| JPMORGAN CHASE & CO | Active fund | 84,699 | +2,584 | $1.9M |
| BANK OF AMERICA CORP /DE/ | Active fund | 521,437 | −1,078 | $11.7M |
RENAISSANCE TECHNOLOGIES LLC holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
ARTIVION, INC. files under SIC 3841 — all 38 surgical & medical instruments & apparatus companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
